1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Non-Alcoholic Steatohepatitis Market – By Product

1.3.2        SAM Non-Alcoholic Steatohepatitis Market – By Application

1.3.3        SAM Non-Alcoholic Steatohepatitis Market – By Sales Channel

1.3.4        SAM Non-Alcoholic Steatohepatitis Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Non-Alcoholic Steatohepatitis Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South And Central America PEST Analysis

4.3         Experts Opinion

5.           SAM Non-alcoholic steatohepatitis (NASH) Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of NASH

5.1.2        Increasing Initiatives for the Awareness of NASH

5.2         Market Restraints

5.2.1        Lack of Established Guidelines in the Diagnosis and Management of NASH

5.2.2        Withdrawal of Drugs from Seeking Marketing Authorization for NASH

5.3         Market Opportunities

5.3.1        Growing Opportunities in Developing Nations

5.3.2        High Competition among Market Players to Manufacture the First Marketed NASH Drug Creates Global Sales Opportunity

5.4         Future Trends

5.4.1        Growing Clinical Trials Involving Combination Studies of Drugs

5.5         Impact Analysis

6.           Non-alcoholic steatohepatitis (NASH) Market– SAM Analysis

6.1         SAM Non-Alcoholic Steatohepatitis Market Revenue Forecast and Analysis

7.           SAM Non-alcoholic steatohepatitis (NASH) Market Revenue and Forecasts To 2028– by Product

7.1         Overview

7.2         Product Market Revenue and Forecast Analysis (US$ Mn)

7.3         Vitamin E and Pioglitazone

7.3.1        Overview

7.3.2        Vitamin E and Pioglitazone Revenue and Forecast to 2028 (US$ Mn)

7.4         Ocaliva

7.4.1        Overview

7.4.2        Ocaliva Revenue and Forecast to 2028 (US$ Mn)

7.5         Elafibranor

7.5.1        Overview

7.5.2        Elafibranor Revenue and Forecast to 2028 (US$ Mn)

7.6         Selonsertib & Cenicriviroc

7.6.1        Overview

7.6.2        Selonsertib Revenue and Forecast to 2028 (US$ Mn)

7.7         Others

7.7.1        Overview

7.7.2        Others Revenue and Forecast to 2028 (US$ Mn)

8.           SAM Non-Alcoholic Steatohepatitis (NASH) Market Analysis and Forecast to 2028 – by Application

8.1         Overview

8.2         Application Market Revenue and Forecast Analysis (US$ Mn)

8.3         Treatment

8.3.1        Overview

8.3.2        Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Diagnosis

8.4.1        Overview

8.4.2        Diagnosis Market Revenue and Forecast to 2028 (US$ Mn)

9.           SAM Non-Alcoholic Steatohepatitis (NASH) Market Analysis and Forecast to 2028 – by Sales Channel

9.1         Overview

9.2         Sales Channel Market Revenue and Forecast Analysis (US$ Mn)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

9.5         Online Provider

9.5.1        Overview

9.5.2        Online Provider Market Revenue and Forecast to 2028 (US$ Mn)

10.        SAM Non-alcoholic steatohepatitis (NASH) Market Revenue and Forecasts to 2028 – Country Analysis

10.1      South and Central America Non-Alcoholic Steatohepatitis Market Revenue and Forecast To 2028

10.1.1     Overview

10.1.3     South and Central America: Non-Alcoholic Steatohepatitis Market, by Country, 2021 & 2028 (%)

10.1.3.1       Brazil: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1.1       Brazil: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1.2       Brazil: Non-Alcoholic Steatohepatitis Market , by Product, 2019–2028 (USD Million)

10.1.3.1.3       Brazil: Non-Alcoholic Steatohepatitis Market, by Application, 2019–2028 (USD Million)

10.1.3.1.4       Brazil: Non-Alcoholic Steatohepatitis Market, by Sales Channel, 2019–2028 (USD Million)

10.1.3.2       Argentina: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.1       Argentina: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.2       Argentina: Non-Alcoholic Steatohepatitis Market , by Product, 2019–2028 (USD Million)

10.1.3.2.3       Argentina: Non-Alcoholic Steatohepatitis Market , by Application, 2019–2028 (USD Million)

10.1.3.2.4       Argentina: Non-Alcoholic Steatohepatitis Market, by Sales Channel, 2019–2028 (USD Million)

10.1.3.3       Rest of South and Central America: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.3.1       Rest of South and Central America: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.3.2       Rest of South and Central America: Non-Alcoholic Steatohepatitis Market , by Product, 2019–2028 (USD Million)

10.1.3.3.3       Rest of South and Central America: Non-Alcoholic Steatohepatitis Market , by Application, 2019–2028 (USD Million)

10.1.3.3.4       Rest of South and Central America: Non-Alcoholic Steatohepatitis Market , by Sales Channel, 2019–2028 (USD Million)

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Cadila Pharmaceuticals Ltd.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Intercept Pharmaceuticals, Inc

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Novartis AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Galmed Pharmaceuticals.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      GENFIT.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Siemens Healthineers AG

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Laboratory Corporation of America Holdings

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Brazil: Non-Alcoholic Steatohepatitis Market , by Product – Revenue and Forecast to 2028 (USD Million)

Table 2.             Brazil: Non-Alcoholic Steatohepatitis Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 3.             Brazil: Non-Alcoholic Steatohepatitis Market, by Sales Channel– Revenue and Forecast to 2028 (USD Million)

Table 4.             Argentina: Non-Alcoholic Steatohepatitis Market , by Product – Revenue and Forecast to 2028 (USD Million)

Table 5.             Argentina: Non-Alcoholic Steatohepatitis Market , by Application– Revenue and Forecast to 2028 (USD Million)

Table 6.             Argentina: Non-Alcoholic Steatohepatitis Market , by Sales Channel– Revenue and Forecast to 2028 (USD Million)

Table 7.             Rest of South and Central America: Non-Alcoholic Steatohepatitis Market , by Product – Revenue and Forecast to 2028 (USD Million)

Table 8.             Rest of South and Central America: Non-Alcoholic Steatohepatitis Market , by Application– Revenue and Forecast to 2028 (USD Million)

Table 9.             Rest of South and Central America: Non-Alcoholic Steatohepatitis Market , by Sales Channel– Revenue and Forecast to 2028 (USD Million)

Table 10.          Organic Developments Done By Companies

Table 11.          Inorganic Developments Done By Companies

Table 12.          Glossary of Terms

LIST OF FIGURES

Figure 1.           SAM Non-Alcoholic Steatohepatitis Market Segmentation

Figure 2.           SAM Non-Alcoholic Steatohepatitis Market, By Country

Figure 3.           SAM Non-Alcoholic Steatohepatitis Market Overview

Figure 4.           SAM Non-Alcoholic Steatohepatitis Market, By Application

Figure 5.           SAM Non-Alcoholic Steatohepatitis Market, By Country

Figure 6.           South And Central America: PEST Analysis

Figure 7.           SAM Experts Opinion

Figure 8.           SAM Non-Alcoholic Steatohepatitis (NASH) Market Impact Analysis of Drivers and Restraints

Figure 9.           SAM Non-Alcoholic Steatohepatitis Market– Revenue Forecast and Analysis

Figure 10.        SAM Product Market Analysis and Forecast 2021 and 2028 (%)

Figure 11.        SAM Vitamin E and Pioglitazone Revenue and Forecast to 2028 (US$ Mn)

Figure 12.        SAM Ocaliva Revenue and Forecast to 2028 (US$ Mn)

Figure 13.        SAM Elafibranor Revenue and Forecast to 2028 (US$ Mn)

Figure 14.        SAM Selonsertib Revenue and Forecast to 2028 (US$ Mn)

Figure 15.        SAM Others Revenue and Forecast to 2028 (US$ Mn)

Figure 16.        SAM Application Market Analysis and Forecast 2021 and 2028 (%)

Figure 17.        SAM Treatment Market Revenue and Forecast to 2028 (US$ Mn)

Figure 18.        SAM Diagnosis Market Revenue and Forecast to 2028 (US$ Mn)

Figure 19.        SAM Sales Channel Market Analysis and Forecast 2021 and 2028 (%)

Figure 20.        SAM Hospital Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

Figure 21.        SAM Retail Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

Figure 22.        SAM Online Provider Market Revenue and Forecast to 2028 (US$ Mn)

Figure 23.        South and Central America: Non-Alcoholic Steatohepatitis Market, by Key Country – Revenue (2021) (USD Million)

Figure 24.        South and Central America: Non-Alcoholic Steatohepatitis Market, by Country, 2021 & 2028 (%)

Figure 25.        Brazil: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        Argentina: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        Rest of South and Central America: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (USD Million)